Safety, pharmacokinetics, and pharmacodynamics of ART‐648, a PDE4 inhibitor in healthy subjects: A randomized, placebo‐controlled phase I study
Abstract Phosphodiesterase 4 (PDE4) inhibitor is associated with a broad‐spectrum anti‐inflammatory mechanism. However, securing clinically efficacious doses with sufficient safety margins remains challenging due to class specific adverse events that are often unavoidable in the clinic. ART‐648 is a...
Saved in:
Main Authors: | Akira Tanaka (Author), Hiroshi Nagabukuro (Author), Kanako Kuniyeda (Author), Haruhi Ando (Author), Toshinori Higashi (Author), Hirokazu Wakuda (Author), Naoyuki Otani (Author), Hideo Kudo (Author), Masae Kuranari (Author), Hidetoshi Furuie (Author), Naoto Uemura (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of ART‐001 with a novel oral pediatric formulation in healthy subjects
by: Akira Tanaka, et al.
Published: (2023) -
Association between psychomotor function and ALDH2 genotype after consuming barley shochu: A randomized crossover trial
by: Keiko Matsuura, et al.
Published: (2023) -
No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug-Drug Interaction Study
by: Naoyuki Otani, et al.
Published: (2019) -
A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK‐1654 in healthy Japanese adults
by: Yuji Orito, et al.
Published: (2022) -
Scientific American Supplement, No. 648, June 2, 1888.
by: Various